A game changing microfludic technology developed at the University of California, San Diego has the potential to address some of the current limitations and accessibility of flow cytometry technology. NanoCellect has exclusively licensed and is further developing the technology into a portable, affordable, and powerful platform capable of providing multicolor detection and sorting of cells and particles.
Investors 1
| Date | Name | Website |
| - | Startup Le... | startuplea... |